What is Myocardial Bridging?
Myocardial bridging consists of muscle fiber bundles overlying an epicardial coronary artery for a variable distance, creating an intramyocardial segment where the artery tunnels through the myocardium rather than running on its surface 1.
Anatomical Characteristics
The condition represents a congenital coronary anomaly where:
- The left anterior descending artery is affected in almost all cases 1
- The muscle overlying the artery is termed the "myocardial bridge"
- The intramyocardial segment is called the "tunneled artery" 2
- The bridge can occur at variable depths and lengths through the myocardium 3
Prevalence and Detection
The reported incidence varies dramatically by detection method:
- Pathological studies: 15-85% (and up to 40-80% in autopsy studies) 1, 4
- Coronary CT angiography: 58% 4
- Invasive angiography: 0.5-4.5% (up to 16% in some series) 1, 4
This discrepancy exists because many bridges are hemodynamically insignificant and only visible on anatomical examination, not during functional imaging 1.
Angiographic Appearance
The typical angiographic presentation is systolic compression of the artery during the cardiac cycle 1. The vessel demonstrates dynamic narrowing during systole, with delayed and incomplete diameter recovery during mid-to-late diastole in symptomatic patients 1.
Clinical Significance
Generally Benign
Most myocardial bridges are innocent anatomical variants without clinical significance 1, 3. The long-term prognosis of isolated myocardial bridges appears excellent 1.
Potential Complications
In specific subsets of patients, myocardial bridging may cause:
- Myocardial ischemia (vessel narrowing from transient myocardial compression) 1
- Myocardial infarction 1
- Malignant ventricular arrhythmias 1
- Atrioventricular block 1
- Sudden cardiac death (rare) 1
High-Risk Features
Pathological studies suggest vessels with tunneled length that is long and deeper than 3 mm beneath the epicardium create the greatest vulnerability for cardiac events 5.
Association with Hypertrophic Cardiomyopathy
Myocardial bridges occur in 30-50% of patients with hypertrophic cardiomyopathy and have been suggested as a possible cause of sudden cardiac death in these patients 1. In HCM, myocardial bridging represents a congenital anomaly whereby overlying myocardium causes systolic compression of an epicardial coronary artery that can persist into diastole, potentially impairing blood flow 6, 7.
Mechanism of Ischemia
The pathophysiology involves:
- Systolic compression of the tunneled arterial segment 1, 2
- Extension into early diastole under conditions of increased heart rate and contractility 8
- Delayed and incomplete vessel diameter recovery during diastole 1
- Tachycardia-mediated limitation of diastolic coronary perfusion time 8
Because coronary perfusion occurs primarily during diastole, most patients have no associated perfusion abnormalities or symptoms 9. However, functional factors such as diastolic dysfunction and coronary vasospasm may exacerbate bridging-related ischemia 9.